Amyotrophic lateral sclerosis: Protein chaperone dysfunction revealed by proteomic studies of animal models
- 7 May 2008
- journal article
- review article
- Published by Wiley in Proteomics – Clinical Applications
- Vol. 2 (5), 670-684
- https://doi.org/10.1002/prca.200780023
Abstract
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease that affects motor neurons and causes progressive muscle weakness and atrophy. The etiology and pathogenesis of ALS are largely unknown and no effective treatment is presently available. About 10% of patients have the familial or inherited form of the disease (fALS), among which 20% is linked to mutations with Cu2+/Zn2+ superoxide dismutase (mSOD1). Transgenic animals expressing human mSOD1 are excellent models for understanding not only fALS but sporadic ALS as well. Pathological features in both ALS patients and mSOD1 transgenic animals' spinal cords share commonalties including the accumulation of misfolded protein inclusions. Recent proteomic investigations on ALS animal models have discovered alterations in protein expression, protein‐protein interactions and post‐translational modifications. These efforts have revealed aspects of potential pathogenic mechanisms and identified probable therapeutic targets. The present review summarizes the major findings of proteomics studies performed on the mSOD1 mice with particular emphasis on the spinal cord proteome. These results are compared with those reported using cell cultures or specimens obtained from ALS patients. The convergence of pathogenic processes on protein chaperone function, and its relationship to protein degradation, metabolic dysfunction and oxidative signaling events is discussed.Keywords
This publication has 94 references indexed in Scilit:
- 14-3-3 protein binds to the low molecular weight neurofilament (NFL) mRNA 3′ UTRMolecular and Cellular Neuroscience, 2007
- Proteomic analysis of spinal cord of presymptomatic amyotrophic lateral sclerosis G93A SOD1 mouseBiochemical and Biophysical Research Communications, 2006
- Depletion of reduced glutathione enhances motor neuron degeneration in vitro and in vivoNeuroscience, 2006
- Neuronal tissue-specific ribonucleoprotein complex formation on SOD1 mRNA: Alterations by ALS SOD1 mutationsNeurobiology of Disease, 2006
- Cystatin C in cerebrospinal fluid and multiple sclerosisAnnals of Neurology, 2006
- Disulfide cross-linked protein represents a significant fraction of ALS-associated Cu, Zn-superoxide dismutase aggregates in spinal cords of model miceProceedings of the National Academy of Sciences of the United States of America, 2006
- Aldolases A and C Are Ribonucleolytic Components of a Neuronal Complex That Regulates the Stability of the Light-Neurofilament mRNAJournal of Neuroscience, 2005
- Co-chaperone CHIP associates with mutant Cu/Zn-superoxide dismutase proteins linked to familial amyotrophic lateral sclerosis and promotes their degradation by proteasomesBiochemical and Biophysical Research Communications, 2004
- p190RhoGEF Binds to a Destabilizing Element in the 3′ Untranslated Region of Light Neurofilament Subunit mRNA and Alters the Stability of the TranscriptPublished by Elsevier BV ,2001
- Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosisNature, 1993